ArticleInternational journal of clinical oncology2026
Re-evaluating the neutropenia-survival paradigm in irinotecan-based therapy for advanced gastric cancer: post-hoc analysis of the RINDBeRG trial.
Tomoki Sakakida et al.PubMed ↗Publisher ↗
No numbers read from the abstract.